It is a randomized controlled trial to assess the efficacy of Ivermectin 12mg in covid-19. Patient recruited will be assigned to two groups one group will be given ivermectin with standard chloroquine regimen and the other group will be receiving chloroquine only. Out come will be recorded by documenting pcr reports at 48, 96 and 144 hours.
Ivermectol 6 Mg it will be a randomized controlled trial which will be done on covid-19 patients proven by pcr fulfilling the criteria (asymptomatic/mild to moderate severity). They will be divided into two groups after randomization. Group a will be administered ivermectin single dose of 12grams along with chloroquine as per existing hospital guidelines and group b will be given chloroquine alone. Dose of ivermectin to be repeated at 1 week if pcr stays negative. Pcr will be done on alternate days (48, 96 and 144hours) and the duration at which the pcr becomes negative will be compared. Dose of drug subject to change in accordance with patient response or possible side effect.